Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Invasive Aspergillosis × Registries × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 4 Neoplasms 3 Lung Neoplasms 2 Chronic Disease 2 Urinary Bladder Neoplasms 1 This Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting. 1 Stress Disorders, Post-Traumatic 1 Parkinson Disease 1 Pain, Intractable 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Non Metastatic Rectal Cancer 1 Neoplasms, Second Primary 1 Muscle Spasticity 1 Multiple Sclerosis 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Invasive Aspergillosis 1 Inflammatory Bowel Diseases 1 Immunoglobulin Light-chain Amyloidosis 1 Huntington Disease 1 Head and Neck Neoplasms 1 Glaucoma 1 Epilepsy 1 Dyskinesias 1 Colonic Neoplasms 1 Autism Spectrum Disorder 1 Anemia, Sickle Cell 1 Adenocarcinoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03221075 2023-05-12

CLARITY

University Hospital of Cologne

Invasive Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡